Risk Factors and Management of Leukopenia Following Kidney Transplantation - A Single-center Experience

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021118

Enrollment

300

Registered

2020-03-20

Start date

2019-12-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z94.0 D70.7

Interventions

Group 1: Kidney or combined kidney and pancreas transplantation AND leukopenia or neutropenia Group 2: Kidney or combined kidney and pancreas transplantation withiout leukopenia or neutropenia

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Kidney transplantation or combined kidney and pancreas transplantation AND leukopenia at the time frame of 2007-2017; control group: kidney transplantation or combined kidney and pancreas transplantation, no leukopenia, sex- and age-matched to leukopenia group

Exclusion criteria

Exclusion criteria: pancytopenia Hb<10g/dL AND platelets <100.000/µL

Design outcomes

Primary

Measure	Time frame
mortality	—

Secondary

Measure	Time frame
creatinine, hospitalization, acute rejection, infection	—

Countries

Germany

Contacts

Public ContactJohanna Schneider

Universitätsklinikum Freiburg

johanna.schneider@uniklinik-freiburg.de0761-270 32842

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026